Podcasts about indiebio

SOSV: Deep Tech Before It Was CoolSOSV wasn't always a billion-dollar fund—it began as a scrappy experiment. Ten years ago, the team was writing $50K checks. Today, it's a global operation with $1.5B under management, backing 60+ new startups annually and running two specialized programs:HAX for hard tech (robotics, industrial, mobility)IndieBio for biotech, food, health, and sustainabilityTheir formula? Hands-on acceleration + deep labs + strategic follow-on capital.“We're not just investors—we're builders. We have scientists and engineers on staff to help startups go from prototype to product faster.”The Global Deep Tech PlaybookBen's career spans Asia (Japan, Korea, China), Silicon Valley, and Europe. While SOSV is a US-based fund, its hard tech accelerator HAX was originally launched in Shenzhen and has since relocated to Newark, NJ. Its biotech program IndieBio began in San Francisco and later expanded to New York City. Today, ~50% of SOSV's portfolio is US-based, with the rest spread across Europe, Asia (notably Singapore), and LATAM.The Vertical Thesis: Climate, Health & IndustrialSOSV focuses on:Climate Tech: From Neptune Robotics cleaning ship hulls to AI-powered food formulationHealth Tech: With over 100 investments, including 20+ in women's healthBiomanufacturing: Startups using biology to produce materials, pharma, food, and solvents sustainablyMatchmaking at Scale: Building Events That Actually WorkFrustrated with event inefficiencies, Ben built his own internal toolset—combining spreadsheets, Python scripts, and LLMs—to run high-efficiency online matchmaking events. These have drawn thousands of VCs and startups, focusing on niche verticals like:BiomanufacturingWomen's HealthClimate Tech (with over 1500 participants and 800 investors)“If it takes me more than an hour to do a repetitive task, I'll just build a tool to automate it.”And yes—SOSV has invested in eight startups discovered through these very matchmaking events.Investing Beyond the ObviousSOSV is known for spotting winners in categories others overlook. Their portfolio spans everything from plant-based AI-designed food (NotCo) to microbe-based mining. As Ben puts it:“We're not afraid to invest in the things that don't have a category yet.”Why Founders Should Get on StageBen spoke at over 300 events—but not for ego. As a self-described "trained shy person," it was a way to build visibility without cold outreach. For founders, the lesson is the same:“It takes three signals to make a tiger. If people hear about you on stage, in media, and from someone they trust—they believe.”In other words, visibility builds credibility.Learn MoreSOSV – Early-stage investor in deep tech and biotechHello Tomorrow – Global Summit for science and deep tech innovation Be sure to follow Sesamers on Instagram, LinkedIn, and X for more cool stories from the people we catch during the best Tech events!

From Utilities to Venture Capital: A Career at the Crossroads of InnovationMatt's career began in the energy sector during a pivotal time of deregulation in California. This early exposure to innovation within legacy industries laid the foundation for a lifelong pursuit: helping large corporations and startups work together to drive transformative change. After 15 years in VC, a stint as an entrepreneur, and a move into corporate venture capital, Matt now leads Syensqo Ventures, a fund backed by one of the world's largest materials science companies.What is Syensqo Ventures?Spun off from Solvay in 2024, Syensqo is a €7B global materials company focused on high-performance, sustainable solutions. Its venture arm—an €80M evergreen fund—invests globally in startups developing advanced materials, often at the intersection of mobility, circularity, bio-based products, and AI-powered materials discovery.Corporate VC with a Strategic EdgeUnlike traditional VCs, Syensqo Ventures looks for strategic alignment. Startups that can benefit from Syensqo's deep material science expertise, infrastructure, or supply chain are most likely to receive investment. “I want to know what Syensqo can do to help accelerate your business,” says Matt.When to Approach Syensqo VenturesThe team invests early—typically at seed or Series A stages—when startups are still figuring out product-market fit and need help with technical validation, de-risking, or market entry. With six team members across the US, Europe, and Asia, they invest globally and often co-invest with financial VCs. They can lead rounds if needed, with typical check sizes ranging from €250K to €3M, and reserves for follow-ons.Key Focus AreasBiomaterials: As demand grows for sustainable consumer products, bio-based inputs are becoming more relevant.Composites & Circular Design: Syensqo is prioritizing innovations that enable lightweight, recyclable, and high-performance materials for aviation, automotive, and consumer goods.AI & Materials Discovery: While AI is lowering the cost of discovery, commercialization still requires partnerships, manufacturing, and distribution—areas where corporates play a key role.Corporate Innovation Isn't a Solo GameMatt emphasizes that innovation doesn't belong solely to startups or corporates—it's a shared journey. Syensqo runs internal R&D, collaborates with universities, and co-develops products with startups. "There's no frontier—just partnerships that accelerate solutions."Circularity by Design: From Targets to ImplementationSyensqo publicly reports on circular sales, using a metric developed with the Ellen MacArthur Foundation. This isn't just marketing—it's part of how the company defines and measures sustainability goals across its value chains. For startups, this signals a strong alignment in building products that are recyclable, bio-based, or reduce environmental impact.Regional Insights & Global AmbitionsWhile the team sees startups following similar patterns globally, they tailor their approach by region—with specific networks in Europe, North America, and Asia. They're active co-investors in funds like Sofinnova and IndieBio, particularly in the biotech and advanced materials space.Learn More about Syensqo VenturesWebsite: Syensqo VenturesLinkedIn: Matt Jones – SyensqoCompany LinkedIn: Syensqo Be sure to follow Sesamers on Instagram, LinkedIn, and X for more cool stories from the people we catch during the best Tech events!

How do we get meat that is more nutritious, sustainable, and less cruel to animals? Dr Uma Valeti, a cardiologist turned CEO of Upside Foods, joins Vasant Dhar in episode 93 of Brave New World to discuss the future of cultivated meat. Useful Resources: 1. Dr Uma Valeti, MD, Upside Foods. 2. Clean Meat - Paul Shapiro. 3. ‘Animal Liberation NOW' - Peter Singer. 4. How India Eats, Vegetarians vs Non Vegetarians percentage in India. 5. Maneka Gandhi On Animal Rights – Episode 44 of Brave New World. 6. Peter Singer On Animal Liberation – Episode 74 of Brave New World. 7. Paul Shapiro on Growing Meat Without Animals – Episode 54 of Brave New World. 8. Sean Sullivan, IndieBio, CPT Capital and Unovis Capital. 9. Cargill, Tyson Foods and Norwest Foods International. 10. CRISPR. 11. The Florida lab-grown meat ban. 12. The Alabama lab-grown meat ban. Check out Vasant Dhar's newsletter on Substack. Subscription is free!  

From growing up in poverty in upstate New York to coining the term "cloud computing" and revolutionising venture capital, Sean O'Sullivan's story is nothing short of remarkable. As Founder and Managing Partner of SOSV, Sean has backed over 1,000 startups through world-renowned programs like IndieBio and HAX, driving breakthroughs in synthetic biology, climate tech, and more. In this episode, Simon Leich dives into Sean's journey, exploring his passion for empowering entrepreneurs, tackling humanity's toughest challenges, and scaling innovations in human and planetary health. Whether you're an entrepreneur, investor, or changemaker, this conversation will inspire and equip you with actionable insights for meaningful impact.--- Hey Climate Tech enthusiasts! Searching for new podcasts on sustainability? Check out the Leaders on a Mission podcast, where I interview climate tech leaders who are shaking up the industry and bringing us the next big thing in sustainable solutions. Join me for a deep dive into the future of green innovation exploring the highs, lows, and everything in between of pioneering new technologies.Get an exclusive insight into how these leaders started up their journey, and how their cutting edge products will make a real impact. Tune in on…YouTube: https://www.youtube.com/@leadersonamissionNet0Spotify: https://open.spotify.com/show/7o41ubdkzChAzD9C53xH82Apple Podcasts: https://podcasts.apple.com/us/podcast/leaders-on-a-mission/id1532211726…to listen to the latest episodes!00:00 – A Studio Model at Scale: SOSV's Unique Approach01:37 – Humble Beginnings: Sean's Journey from Poverty to Innovation08:12 – The Creator of Cloud Computing and Ride-Sharing10:34 – Biology Meets Innovation: Why IndieBio Leads the Future15:13 – Inside IndieBio: Building Community to Drive Change20:37 – Global Entrepreneurs: Innovation Without Borders31:06 – Sustainable Production for a Growing Planet.37:54 – Navigating the Boom-and-Bust Cycles of Venture Capital43:12 – The Future of Innovation: Sean's Vision for SOSV and BeyondUseful links: SOSV's website: https://sosv.com/                                SOSV's LinkedIn: https://www.linkedin.com/company/sosv/                              Sean O'Sullivan's LinkedIn: https://www.linkedin.com/in/sean-sosv/                Leaders on a Mission website: https://cs-partners.net/podcasts/Simon Leich's LinkedIn: https://www.linkedin.com/in/executive-talent-headhunter-agtech-foodtech-agrifoodtech-agritech/

We are so excited to introduce today's guest, Carolina Reis Oliveira, who is the co-founder and CEO of OneSkin.  Carolina holds a biochemistry degree and a Ph.D. in stem cell biology and is an alumnus of IndieBio, the world's leading biotechnology accelerator. She relocated to Silicon Valley from Latin America in 2016 to co-found OneSkin, a biotech company developing solutions to target skin aging at the molecular level and extend the health of your skin and body. Carolina is leading the development of the anti-senescence topical product designed to maximize skin health, recently launched via e-commerce. She is a co-inventor of 3 patents,  co-author of numerous scientific publications, and has been an advocate of skin health in the longevity community.   In this episode we discuss: Why skin health is important to overall longevity and how it can impact our body's  inflammation.  How OneSkin's OS-1 peptide can improve the health of your skin by repairing damaged cells and rejuvenate your skin from the inside out (i.e. treat the root cause of aging).  The clinical studies that show the effectiveness of OneSkin's products to improve elasticity and protect the skin barrier to reduce the appearance of fine lines. How their products stimulate the skin to do the work itself so that it can look and function well.   How OneSkin's products can integrate with your existing skin care routine and procedures. Helpful links and resources: One Skin IG: @oneskin.co and @carolina.reis.phd FB: https://www.facebook.com/OneSkinTech Special offer:  Use code 'livingwell' for 15% off your purchase --------------------------------------------------------- Thanks to our amazing Sponsor, Vivarays Are you looking for a way to improve your sleep and boost your energy during the day? Meet Vivarays' Circadian Light Harmonizing Glasses! Unlike regular blue light blockers, these glasses are engineered with a deep understanding of light and its impact on your body. Designed by leading sleep experts, Vivarays helps keep your circadian rhythm in sync with nature, improving your hormonal balance, sleep quality, energy levels and productivity. Head over to https://vivarays.com/livingwell to check out their amazing glasses and use promo code ARTOFLIVINGWELL during checkout to save 10%. --------------------------------------------------------- Need more protein in your day? Check out these amazing, high quality products from Kion, especially their essential amino acids, which we both use daily.   Use code 'ARTOFLIVING' for a discount off your purchase. ----------------------------------------------------------- Ask us a question/make a recommentation We'd love to hear from you! Click here to share your feedback and suggestions. ----------------------------------------------------------- Sign-up for your 15 minute Health Transformation Audit - Click here. ----------------------------------------------------------- Vitality Reboot Fall Detox 2024 - Sept.22-28th Revitalize Your Life in Just 7 Days! This program is designed to leave you feeling refreshed, energized, and ready to embrace the fall season ahead! Join our fabulous community!   Register here! ----------------------------------------------------------- Let us help you get to the root cause of your unwanted symptoms. Schedule a 15 minute consultation to discuss at-home functional medicine lab testing here. ----------------------------------------------------------- How can you support our podcast? Apple users, please subscribe and review our show on Apple Podcasts,we make sure to read them all. Android users, please be sure to subscribe to our show on Google Podcasts so that you don't miss any of the action. Tell a friend about The Art of Living Well Podcast® and our community programs. Share your favorite episode on social media and don't forget to tag us @theartofliving_well. Subscribe to our Youtube channel Shop our Favorite Products: https://www.theartoflivingwell.us/products Connect with us on social media: IG: @theartofliving_well FB: theartoflivingwell Get on our list so you don't miss out on announcements, programs and events. You can download our guests' favorite reads here. Learn more about your hosts: Marnie Dachis Marmet Stephanie May Potter    

In this episode of The Remote CEO Show, I had the pleasure of interviewing Michael Gasiorek. Michael Gasiorek is a founder, writer, and community builder running Truth Cartel, a "belief distribution agency" for Web3 companies like Algorand and Republic. They specialize in content marketing and public relations. He have written for Fortune and Inc, co-authored books with Derek Sivers, and mentor deep tech startups at dLab.vc and IndieBio.

Here Dr Reis talks about what causes aging of the skin, and UVB is one of the main causes and what her longevity protocol looks like. Dr. Carolina Reis is the co-found and CEO of OneSkin Technologies. She holds a biochemistry degree and a Ph.D. focused on stem cell and tissue engineering. After more than 10 years of developing science in academia, she is thrilled to translate basic science into products that will extend our healthspan. As a founder of OneSkin, she and the team have been working to develop the first anti-senescence topical product designed to promote skin health from within. Dr. Reis is an alumnus of IndieBio, the world's largest seed biotech accelerator. She has moved from Latin America to Silicon Valley 4 years ago to found OneSkin and has been actively engaged in the longevity ecosystem in the Bay Area.

Here Dr Reis talks about some of the customer feedback that they have received. The feedback is available at the bottom of the product pages on the OneSkin website. Dr. Carolina Reis is the co-found and CEO of OneSkin Technologies. She holds a biochemistry degree and a Ph.D. focused on stem cell and tissue engineering. After more than 10 years of developing science in academia, she is thrilled to translate basic science into products that will extend our healthspan. As a founder of OneSkin, she and the team have been working to develop the first anti-senescence topical product designed to promote skin health from within. Dr. Reis is an alumnus of IndieBio, the world's largest seed biotech accelerator. She has moved from Latin America to Silicon Valley 4 years ago to found OneSkin and has been actively engaged in the longevity ecosystem in the Bay Area.

In this panel discussion from SOSV's 2024 EarthDay+ sessions (Apr 22-26, 2024) moderated by Dr. Pae Wu of IndieBio and SOSV, corporate venture capitalists Brandon Middaugh from Microsoft's Climate Innovation Fund, Taehong Huh from GS Futures, and Aditya Sharma from Honda Innovations discussed their strategies for investing in climate tech startups.They emphasize the importance of early engagement with startups, strategic alignment with corporate goals, and the necessity for startups to understand their market and competition.They highlight the challenges of scaling up technology in the climate sector, particularly the capital intensity and longer timelines associated with hardware innovations.They advise startups on navigating corporate structures and leveraging intellectual property effectively.The conversation underscored the evolving role of corporate venture capital in fostering innovative climate technologies and the collaborative approach required to drive significant advancements in decarbonizing industries.The video of this episode and more can be found online at sosvclimatetech.com.SpeakersBrandon Middaugh, Senior Director, Climate Innovation Fund, MicrosoftTaehong Huh, Managing Partner, GS FuturesAdity Sharma, Principal, Honda InnovationsModeratorDr. Pae Wu, CTO, IndieBio; General Partner, SOSVCreditsProducer: Ben Joffe Podcast Summary: Written by gpt-4-turbo, edited by Ben JoffeIntro Voice: Cloned voice of Ben Joffe by ElevenLabs Intro Music: EL WailiKeywords: #deeptech #venturecapital #climatetech #vc #robotics #lifesciences #biology #hardware #startups #innovation #technology #frontiertech #hardtech #energy #decarbonizationHosted by Ausha. See ausha.co/privacy-policy for more information.

Here Dr Reis talks about the human as well as in vitro trials that her company is doing. The papers can be found on the OneSkin website (including the one that she refers to in the video as being published in the next week) Dr. Carolina Reis is the co-found and CEO of OneSkin Technologies. She holds a biochemistry degree and a Ph.D. focused on stem cell and tissue engineering. After more than 10 years of developing science in academia, she is thrilled to translate basic science into products that will extend our healthspan. As a founder of OneSkin, she and the team have been working to develop the first anti-senescence topical product designed to promote skin health from within. Dr. Reis is an alumnus of IndieBio, the world's largest seed biotech accelerator. She has moved from Latin America to Silicon Valley 4 years ago to found OneSkin and has been actively engaged in the longevity ecosystem in the Bay Area.

Here Dr Reis talks about the new series of products that the team at OneSkin have developed, including for body, eyes, sun protection and a cleanser. Dr. Carolina Reis is the co-found and CEO of OneSkin Technologies. She holds a biochemistry degree and a Ph.D. focused on stem cell and tissue engineering. After more than 10 years of developing science in academia, she is thrilled to translate basic science into products that will extend our healthspan. As a founder of OneSkin, she and the team have been working to develop the first anti-senescence topical product designed to promote skin health from within. Dr. Reis is an alumnus of IndieBio, the world's largest seed biotech accelerator. She has moved from Latin America to Silicon Valley 4 years ago to found OneSkin and has been actively engaged in the longevity ecosystem in the Bay Area.

Here Dr Reis talks about the development of OS-1 the peptide used in One Skins products, its senomorphic effects and other ingredients which are included in the One Skin product range. Dr. Carolina Reis is the co-found and CEO of OneSkin Technologies. She holds a biochemistry degree and a Ph.D. focused on stem cell and tissue engineering. After more than 10 years of developing science in academia, she is thrilled to translate basic science into products that will extend our healthspan. As a founder of OneSkin, she and the team have been working to develop the first anti-senescence topical product designed to promote skin health from within. Dr. Reis is an alumnus of IndieBio, the world's largest seed biotech accelerator. She has moved from Latin America to Silicon Valley 4 years ago to found OneSkin and has been actively engaged in the longevity ecosystem in the Bay Area.

Carolina Reis holds her Ph.D. in Immunology and is an alumnus of IndieBio, the world's leading biotechnology accelerator. In 2016, Carolina relocated to Silicon Valley from Latin America to co-found OneSkin, and to lead the development of the company's disruptive rejuvenation technologies. 15 Daily Steps to Lose Weight and Prevent Disease PDF: https://bit.ly/46XTn8f - Get my FREE eBook now! Become a Genius Life Premium Member! Learn more: http://thegeniuslife.com This episode is proudly sponsored by: Kion makes one of my absolute favorite whey isolate protein powders and also a go-to source of creatine. Save 20% by going to http://getkion.com/geniuslife. First Light Farms produces beautiful, delicious, grass-fed meats on their pristine New Zealand farm, and ships them straight to your doorstep. Visit http://firstlight.farm and use code MAX15 for 15% off.

Mohan Iyer is a General Partner at SOSV and a Partner at IndieBio. Mohan carries deep operational experience with more than 25 years as an entrepreneur and leader at several life science startups where he enjoyed developing strategy, building successful teams, executing against complex operational goals, fundraising in good times and bad, and forging creative sell-side strategic partnering and M&A deals. Having walked in these shoes, he is passionate about serving genius entrepreneurs to realize their mission of a better world by creating, scaling, and exiting meaningful new companies.

On this episode of My Climate Journey, we have two guests: Susan Schofer and Po Bronson.Susan is partner at SOSV and Chief Science Officer at Hax, which is SOSV's initiative around hard tech. She has a PhD in chemistry from Caltech, and most recently spent eight years at Modern Meadow, a growth stage startup in the bio leather space.Po is general partner at SOSV, and managing director of IndieBio, which is SOSV's initiative around biotech. Po has written seven New York Times bestsellers, and has won nine national awards for science journalism.Cody and our guests cover Susan and Po's backgrounds, the challenges in evaluating material science startups, their journeys from academia and the food industry, and early-stage deep tech investment models. They also discuss business economics in material science startups, scaling challenges, sustainable sourcing, and the potential and limitations of synthetic biology in the context of material science startups.In this episode, we cover: [02:01]: Susan and Po's roles at SOSV[03:08]: The complexity of evaluating material science startups[04:49]: Susan's journey from chemistry academia to industry[07:13]: Po's transition from the food industry and writing to IndieBio[09:12]: Comparing Hax's and IndieBio's methodologies within SOSV[11:54]: SOSV's early-stage deep tech investment model[14:46]: Business economics in material science startups[17:11]: Unmet needs and sustainable sourcing in materials[19:48]: The critical role of performance in bio-based materials[22:22]: Scaling challenges in sustainable startups[24:08]: “Pure” vs. blended materials[30:54]: Scaling issues faced by bioleather companies[34:35]: Trends in the plastics space and circularity[37:15]: Challenges in the cosmetics and skincare industry[41:47]: Defining terms “biomanufacturing,” “bioeconomy,” and “synthetic biology”[45:07]: Challenges in biology vs. chemistry[51:35]: Susan and Po's advice for foundersEpisode recorded on Jan 16, 2024 (Published on Feb 20, 2024) Get connected with MCJ: Jason Jacobs X / LinkedInCody Simms X / LinkedInMCJ Podcast / Collective / YouTube*If you liked this episode, please consider giving us a review! You can also reach us via email at content@mcjcollective.com, where we encourage you to share your feedback on episodes and suggestions for future topics or guests.

To check out OneSkin click here!  https://shareasale.com/u.cfm?d=1054216&m=102446&u=3821794&afftrack= To get your 15% one time use discount use code: Confidence Remember if you opt in for the subscription you can cancel any time but you can only use the discount code once. In This Episode You Will Learn About:  How scientifically proven ingredients can revolutionize your skin Why feeling beauty from within boosts your whole outlook What happens when you simplify your skincare routine Why OneSkin is for everyone! Resources: Website: https://www.oneskin.co/  Instagram: @caroll_reis & @oneskin.co Facebook: @OneSkin YouTube: @OneSkin Technologies LinkedIn: Carolina Reis Oliveira Visit heathermonahan.com Overcome Your Villains is Available NOW! Order here: https://overcomeyourvillains.com  Sign up for a one-dollar-per-month trial period at shopify.com/monahan Right now you can get Two Memberships for the Price of One at masterclass.com/monahan Get a sponsored job credit of $75 to enhance the visibility of your jobs at Indeed.com/monahan  Show Notes:  It's time to REVERSE your skin's age! Today I welcome back Carolina Oliveira, the CEO and co-founder of OneSkin, the groundbreaking skincare disrupter. All OneSkin products are formulated with OS-01, the first ingredient scientifically proven to reverse skin's biological age at the molecular level. And it's amazing to see the results! Even my dermatologist is blown away by my skin's health and improvement over the last few months. But don't just take my word for it. Treat yourself this holiday season and try OneSkin for yourself! Start ticking back that clock! About The Guest: Carolina Oliveira holds her Ph.D. in Immunology at the Federal University of Minas Gerais in collaboration with Rutgers University and is an alumnus of IndieBio, the world's leading biotechnology accelerator. In 2016, Carolina relocated to Silicon Valley from Latin America to co-found OneSkin, and to lead the development of the company's disruptive rejuvenation technologies. If You Liked This Episode You Might Also Like These Episodes: #351: Unlocking The Secret To Age Reversal with Carolina Oliveira Co-founder & CEO at OneSkin #324: The POWER Of Letting Go With Heather! #322: You Are NOT Alone With Heather! Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode of Habits and Hustle, I chat with OneSkin co-founders, Carolina Reis Oliveira and Alessandra Zonari, who share the revolutionary product ingredient that they basically founded that truly does help reverse aging. Carolina and Alessandra bring a unique perspective to skincare, with their impressive academic backgrounds in stem cell biology and tissue engineering. This episode is filled with insights into the world of anti-aging skincare, the science of skin aging, and the role of senescent cells in aging. We dive deep into the effectiveness of skincare products and the journey of transitioning from academia to entrepreneurship. This includes the challenges of securing funding, finding the right investors, and bringing a product to market. Additionally, it underscores the importance of staying connected with customers and shares useful skincare tips. Carolina and Alessandra are co-founders of OneSkin, a biotechnology company developing disruptive rejuvenation technologies. Carolina, with a Ph.D. in Immunology from the Federal University of Minas Gerais in collaboration with Rutgers University, and an IndieBio alum, relocated to Silicon Valley from Latin America in 2016 to co-found OneSkin and spearhead the development of groundbreaking rejuvenation technologies. Alessandra, the co-founder and Chief Scientific Officer, holds a Master's degree in stem cell biology and a Ph.D. in skin regeneration and tissue engineering from the Federal University of Minas Gerais, Brazil, in collaboration with the 3B's Research Group in Portugal. She is also credited with co-inventing three patents and publishing 20 peer-reviewed papers in scientific journals. What we discuss: (01:50) - Carolina and Alessandra share their academic backgrounds in stem cell biology and tissue engineering and how they transitioned from academia to entrepreneurship (14:27) - Exploring the science of skin aging, explaining the role of retinol and its impact on skin appearance (21:12) - The concept of senescent cells and their contribution to aging, exploring research on how to reduce the accumulation of these cells in skin tissues. (37:43) - The effectiveness of One Skin products, their approach to skincare, and the science behind their Eye Cream product. (43:15) - Carolina and Alessandra share their entrepreneurial journey, from securing funding to finding the right investors, and the challenges they faced in bringing their product to market. (52:19) - The importance of staying connected with their customers, how their product works, and tips on skincare. Thank you to our sponsors: TruNiagen: Head over to truniagen.com and use code HUSTLE20 to get $20 off any purchase over $100. Find more from Jen:  Website: https://www.jennifercohen.com/ Instagram: @therealjencohen  Books: https://www.jennifercohen.com/books Speaking: https://www.jennifercohen.com/speaking-engagement Learn more from OneSkin: Website: https://www.oneskin.co/ Instagram: https://www.instagram.com/oneskin.co/ Learn more about your ad choices. Visit megaphone.fm/adchoices

In this discussion from the 2023 SOSV Climate Tech Summit (Sept 26-27, 2023), four investors discuss the importance of early stage funding and the need for startups to show traction and progress. They also highlight the potential of untapped sectors such as cement and agriculture in driving climate tech innovation. The conversation touches on the role of government regulation and incentives in supporting the growth of the climate tech industry. This conversation is moderated by Alex Wilhelm, Editor in Chief at TechCrunch. The video of this episode and more can be found online at sosvclimatetech.com. Speakers Laurie Menoud, Founding Partner, AtOne Stephanie Dorsey, Founding Partner, E2JDJ Corinna Chen, Partner, Material Impact Dr. Pae Wu, SOSV General Partner, IndieBio CTO Moderator Alex Wilhelm, TechCrunch, Editor in Chief Credits Producer: Ben Joffe  Podcast Summary: Written by gpt-3.5-turbo, edited by Ben Joffe Intro Voice: Cloned voice of Ben Joffe by ElevenLabs  Intro Music: EL Waili Keywords: #deeptech #venturecapital #climatetech #vc #robotics #lifesciences #biology #hardware #startups #innovation #technology #frontiertech #hardtech

Today we have Sean O'Sullivan with us. Sean is a Managing General Partner at SOSV, a global, multi-stage venture capital firm that operates early stage startup development programs, notably HAX, IndieBio, and Orbit Startups. They are the first check in deep tech, starting at pre-seed.SOSV have a $1.5 Billion in AUM and an established portfolio of 1000+ companies including Upside Foods, Perfect Day, Opentrons, and Formlabs. Sean is on the board of Khan Academy, the Tyndall Institute, the Autism Impact Alliance, the Brain Foundation, and a number of private companies.From serving as a janitor to embracing his passions as a musician, filmmaker, and even running a humanitarian organization in Iraq, Sean O'Sullivan's multifaceted nature reveals a remarkable tapestry of life experiences. Among the intriguing anecdotes is his encounter with a rare viral infection that affected his eye, providing a testament to resilience and adaptability. His ventures extended to the world of television, where he enjoyed a stint as a TV star in Ireland, further exemplifying his versatility.In conclusion, Sean O'Sullivan's venture journey offers a tapestry of experiences, showcasing the significance of perseverance, long-term commitment, and a diverse entrepreneurial mindset. These insights have molded his investment philosophy, guiding SOSV's strategic approach to support startups in their earliest stages and nurture their growth through series B and series C, while emphasizing the immeasurable value of riding the wave with successful companies for the long haul.

To check out OneSkin click here!  https://shareasale.com/u.cfm?d=1054216&m=102446&u=3821794&afftrack= To get your 15% one time use discount use code: Confidence Remember if you opt in for the subscription you can cancel any time but you can only use the discount code once. In This Episode You Will Learn About:  The determination it takes to get a passion project off the ground How to pivot from a creator to a marketer Using science to reverse the aging process What rejuvenating your skin will do for your life Resources: Website: https://www.oneskin.co/  Instagram: @caroll_reis & @oneskin.co Facebook: @OneSkin YouTube: @OneSkin Technologies LinkedIn: Carolina Reis Oliveira Visit heathermonahan.com Overcome Your Villains is Available NOW! Order here: https://overcomeyourvillains.com  Sign up for a one-dollar-per-month trial period at shopify.com/monahan Go to bit.ly/pipedrive-confidence for a 14-day free trial and get 20% off Pipedrive for 1 year! Head to factormeals.com/confidence50 and use code confidence50 to get 50% off. Go to cozyearth.com and get up to 35% off site wide when you use the code “CONFIDENCE” Show Notes:  Have you ever wondered what it might feel like to totally rejuvenate your skin? I have been fighting wrinkles, inflammation, and acne for years but I have never seen results like I have with OneSkin products. The incredible creator and CEO of OneSkin, Carolina Oliveira joins us today to describe how she went from a scientist in Brazil to a groundbreaking entrepreneur in Silicon Valley. The key to her success is twofold: PURPOSE and DATA! She doesn't leave anything to chance. Her products are PROVEN to work! And I can attest to that. Give OneSkin a chance and see what it does for you! About The Guest: Carolina Oliveira holds her Ph.D. in Immunology at the Federal University of Minas Gerais in collaboration with Rutgers University and is an alumnus of IndieBio, the world's leading biotechnology accelerator. In 2016, Carolina relocated to Silicon Valley from Latin America to co-found OneSkin, and to lead the development of the company's disruptive rejuvenation technologies. If You Liked This Episode You Might Also Like These Episodes: Why Your Mindset Is The KEY To Success! With Sara Blakley & Jesse Itzler  Discover The Root Of Your Confidence, With Nicole Kalil Author & Host Of This Is Women's Work Podcast  How to Make Things Happen with Heather & Kelley Tyan, Author & Success Coach!  Learn more about your ad choices. Visit megaphone.fm/adchoices

Episode Description: We dive deep into the fascinating intersection of science fiction and real-world innovation. Sabriya Stukes, shares her journey from a microbiologist researching tuberculosis and HIV to the fast-paced world of startups and business. We explore the "Science Fiction Idea Bank," a reservoir of futuristic concepts that have inspired today's technological advancements. From artificial silk to the societal implications of fictional drugs, this episode is a testament to the power of imagination and its role in shaping our reality. Grow Everything brings to life the bioeconomy when hosts Karl Schmieder and Erum Azeez Khan share stories from the field and interview leaders and influencers in the space.  Life is a powerful force and it can be engineered. What are we creating? Learn more at www.messaginglab.com/groweverything Topics Covered: 00:00:00 Introduction: The Intersection of Science Fiction and Biotech Innovation 00:01:20 The "Science Fiction Idea Bank": Fueling Today's Technological Breakthroughs 00:05:32 How Sci-fi Visions Pave the Way for Startup Innovations 00:09:20 Biotech Wonders: From Imaginary Implants to Performance-enhancing Drugs 00:11:41 Sabriya Stukes: From Microbiologist to Startup Success 00:14:23 Indie Bio's Mission: Molding Scientists into Savvy Entrepreneurs 00:21:28 Weighing Career Paths: Scientist vs. Entrepreneur 00:24:14 Merging Worlds: Introducing Business Acumen to Scientific Endeavors 00:27:58 Evaluating Biotech Startups: The Thrills and Complexities 00:30:22 Key Elements of Biotech Success: Funding and Market Needs 00:33:46 Winning Over Investors: The Art of Storytelling in Biotech 00:35:09 Crafting a Biotech Venture: Passion and Effective Communication 00:41:00 Merging Business and Science: A Comprehensive Approach to Startup Analysis 00:49:31 Community's Role in Nurturing and Supporting Biotech Ventures 00:51:03 From Small Victories to Major Breakthroughs: A Glimpse into Startup Growth 00:52:06 Celebrating Milestones: Achievements in a Biotech Food Program 00:55:22 Indie Bio's Legacy: Leading Investor in Promising Biotech Startups 01:00:05 Networking and Crafting a Compelling Biotech Investment Narrative Episode Links: LinkedIn IndieBio Twitter Instagram SOSV Not Boring SciFi Idea Bank Technovelgy.com Captagon: the drug fuelling the Gulf party scene - and Syria's finances AIMA - CBD period pain relief Nukoko- cocoa free chocolate Climate Capital on what founders needs Call or Text the Grow Everything Hotline:  +1 804-505-5553 Have a question or comment? Message us here: Instagram / TikTok / Twitter / LinkedIn / Youtube / GrowEverything website Email: groweverything@messaginglab.com Support here: Patreon Music by: Nihilore Production by: Amplafy Media --- Send in a voice message: https://podcasters.spotify.com/pod/show/messaginglab/message

TO GET THE FULL SHOW NOTES, GO TO https://antiaginghacks.net/podcast/oneskin-peptide-reverse-facial-aging/ [Sponsor Episode: To get thicker, fuller and stronger hair, try FullyVital hair wellness products. They are natural and free of drugs and chemicals] OneSkin has provided a discount code of 15% when you use the code antiaginghacks at checkout. Carolina holds her Ph.D. in Immunology at the Federal University of Minas Gerais in collaboration with Rutgers University and is an alumnus of IndieBio, the world's leading biotechnology accelerator. In 2016, Carolina relocated to Silicon Valley from Latin America to co-found OneSkin, and to lead the development of the company's disruptive rejuvenation technologies. Here are the topics of discussion: 03:00 How Carolina got Into Skin 09:55 How Did Their SkinAge Clock Differentiate From Other Methylation Clocks? 13:10 Why OneSkin Is Targeting Senescent Cells? 16:40 How They Found The Right Combination Of Peptides For Targeting Senescent Cells? 20:20 What's Included In The Skin Serums? 25:40 Where OneSkin gets the skin samples to test? 27:20 How Does OneSkin Ensure Penetration Into Skin? 30:00 What Should People Expect After Using OneSkin? 32:23 Why To Use Under Eye Serum Vs. Face Serum? 35:30 How Does OneSkin Fit Into Your Daily Skin Routine? 38:40 How To Use OneSkin with In-Office Treatments? 41:10 Where You Can Get OneSkin products?  

Our skin was designed to function as a barrier to protect our bodies from environmental stressors and pathogens, but unfortunately, our skin barrier is one of the main factors that is compromised as we age. Many of us are constantly looking for the next best thing to slow down and possibly even reverse these signs of skin aging, and my guest today is here to explain why focusing on products that work on the molecular level is the key to healthy aging.   I'm joined by Carolina Oliveira, the CEO and co-founder of OneSkin, to discuss everything you need to know about healthy aging in the skin. We cover cellular senescence, biological age, systemic inflammation, and the research being done at OneSkin to quantify these things. We also talk about some of the other factors that have an impact on skin health, and of course dive into the first peptide developed to reverse skin aging at the molecular level: OS-O1.   Carolina Oliveira is the CEO and co-founder of OneSkin. She holds a Ph.D. in stem cell biology and tissue engineering, is a co-inventor of 5 patents and co-author of numerous scientific publications. She relocated from Brazil to Silicon Valley in 2016 to found OneSkin, a fast-growing longevity company developing products to promote skin health by targeting aging at the molecular level. Carolina is an alumnus of IndieBio, the world's largest biotech accelerator and has been an active voice in the longevity field, pioneering age reversal skin research with OneSkin.  Thank you to our sponsors for making this episode possible: OneSkin: Use code SUPERHUMAN15 at https://www.oneskin.co/ BiOptimizers: For Sleep Breakthrough use code BIONAT10 at checkout to save 10% at sleepbreakthrough.com/bionat Berkeley Life: Consumers may register and place an order using my code NIDDBL for 10% off at berkeleylife.com Neurohacker Collective: https://bit.ly/QNHNat and use code NN15 Find more from Nathalie: YouTube: https://www.youtube.com/channel/UCmholC48MqRC50UffIZOMOQ Facebook Group: https://www.facebook.com/groups/biohackingsuperhumanperformance Instagram: https://www.instagram.com/nathalieniddam/ Website: NatNiddam.com Join Nat's Membership Community: https://www.natniddam.com/bsp-community Work with Nat: Book Your 20 Minute Optimization Consult: https://calendly.com/nniddam/intro-call?month=2021-08   Find more from Carolina Oliveira: Website: oneskin.co   What we discuss: [00:03:24] The skin barrier and why our skin becomes more fragile as we age [00:08:30] Does nutrition have a big impact on skin health? [00:16:05] The skin's biological age clock [00:22:48] Does cellular senescence affect skin elasticity? [00:28:07] Ingredients to avoid when looking for skincare  [00:35:37] How long does it take to see results from OneSkin products?  [00:43:22] How OneSkin products can potentially lower systemic inflammation [00:50:09] The different concentration of OS-O1 in each product Key Takeaways: Cellular senescence is a process in which cells stop dividing after reaching their replication limit of around 50 times. These cells have accumulated various mutations that can lead to cancer if they continue to divide. Therefore, cellular senescence functions as a protective mechanism for the body. However, these senescent cells also secrete inflammatory signals that can cause neighboring cells to age faster. When it comes to choosing skincare products, it is important to pay attention to the ingredients list. Some ingredients, like parabens and fragrance, can cause irritation or harm to the skin. Parabens are preservatives that have been linked to endocrine disruption, while fragrance can cause allergic reactions or sensitivity.  Websites like EWG can be a helpful resource for checking the safety of skincare products and their ingredients.  Advanced Glycation End-products (AGEs) are naturally occurring compounds that are formed when glucose reacts with proteins in the body. The accumulation of AGEs in the skin leads to the degradation of collagen and elastin fibers, which are responsible for keeping the skin firm and elastic.  

Growing up in a small town in the countryside of Brazil, Carolina Reis was always fascinated with “the code of life.” While studying stem cell biology and tissue engineering, Carolina sought for a way to use her knowledge to build a scalable, sustainable company. After relocating to Silicon Valley, Carolina and three other scientists united in their passion to develop solutions to prolong human healthspan. In this episode, we will learn about Carolina's mission in founding the company OneSkin and how our skin can impact our overall health. We will also discuss how to reduce biological aging, why we need healthy skin habits to thrive, and how we can increase our “skin span.” Carolina Reis is a scientist and the co-founder and CEO of OneSkin, a biotechnology company working to fight humanity's oldest problem…aging. Fueled by their passion for science and love of life - Carolina and three other women Ph.D. scientists joined forces to create the pioneering skincare company OneSkin to forever transform the way humans experience aging. In this episode, Hala and Carolina will discuss:  - Why OneSkin is pro-aging - The science behind aging   - The problem with traditional anti-aging products - Why people live the longest in Blue Zones - Increasing skin span - The connection between our skin and our brain - Carolina's thoughts on botox - And other topics… Carolina Reis is a biotechnology entrepreneur and the founder of OneSkin. As a founder of OneSkin, she and the team have been working to develop the first anti-senescence topical product designed to promote skin health from within. She holds a biochemistry degree and a Ph.D. focused on stem cell and tissue engineering. After more than 10 years of developing science in academia, she is thrilled to translate basic science into products that will extend our health span.  Carolina is an alumnus of IndieBio, the world's largest seed biotech accelerator. She moved from Latin America to Silicon Valley 4 years ago to found OneSkin and has been actively engaged in the longevity ecosystem in the Bay Area.  Resources Mentioned: Carolina's Website: https://www.oneskin.co/  Carolina's LinkedIn: https://www.linkedin.com/in/carolina-reis-oliveira-a69b8a27/ Carolina's Twitter: https://twitter.com/Carol_roliveira OneSkin's Instagram: https://www.instagram.com/oneskin.co/ OneSkin's Facebook: https://www.facebook.com/OneSkinTech Skincare Ingredient Checker: https://www.thinkdirtyapp.com/  LinkedIn Secrets Masterclass, Have Job Security For Life: Use code ‘podcast' for 30% off at yapmedia.io/course. Sponsored By:  Shopify - Sign up for a $1 per month trial period at youngandprofiting.co/shopify Masterclass - Go to masterclass.com/profiting for 15% off an annual membership. The Millionaire University Podcast - So take the next step to earning 7 figures with your business… listen to The Millionaire University Podcast! More About Young and Profiting Download Transcripts - youngandprofiting.com/episodes-new/ Get Sponsorship Deals - youngandprofiting.com/sponsorships Leave a Review - ratethispodcast.com/yap Watch Videos - youtube.com/c/YoungandProfiting Follow Hala Taha LinkedIn - linkedin.com/in/htaha/ Instagram - instagram.com/yapwithhala/ TikTok - tiktok.com/@yapwithhala Twitter - twitter.com/yapwithhala Learn more about YAP Media Agency Services - yapmedia.io/ Learn more about your ad choices. Visit megaphone.fm/adchoices

Arvind Gupta co-leads Mayfield's engineering biology practice and is Founder and Venture Advisor at IndieBio. He was the first investor in breakout bio companies such as Geltor, Synthex, Prime Roots, NotCo, Prellis, New Culture, DNA Lite and Memphis Meats. As Founder of IndieBio, Arvind redefined the pace and possibilities of early stage biotech, investing in over 136 companies in five years, defining human and planetary health, and growing the IndieBio portfolio into billions of dollars in value. Prior to founding IndieBio, Arvind was Design Director at IDEO in Shanghai where he earned numerous international design awards. He is also a co-author of Decoding the World: A Roadmap for the Questioner, and a frequent speaker at TechCrunch Disrupt, Slush, TedX and Future FoodTech. He received his B.S. in Genetic Engineering from UCSB. He holds 8 patents. About VSC Ventures: For 20 years, our award-winning ⁠PR agency VSC⁠ has worked with innovative startups on positioning, messaging, and awareness and we are bringing that same expertise to help climate startups with storytelling and narrative building. Last year, general partners Vijay Chattha and Jay Kapoor raised a $21M fund to co-invest in the most promising startups alongside leading climate funds. Through the conversations on our show CLIMB by VSC, we're excited to share what we're doing at VSC and VSC Ventures on climate innovation with companies like ⁠Ample⁠, ⁠Actual⁠, ⁠Sesame Solar⁠, ⁠Synop⁠, ⁠Vibrant Planet⁠, and ⁠Zume⁠ among many others.

“We now are in this moment where we have access to information and we have the power to act and to choose what we are doing in our daily lives. And the more that we understand and learn about biology, the more we know that we have control of it. We have the power in our hands and it's up to us to make the right choices.” - Dr. Carolina Reis, Ph.D., Co-Founder, and Chief Executive Officer Today's returning guest for round 2, is Dr. Carolina Reis Oliveira, co-founder, and CEO of OneSkin, a fast-growing longevity company developing products to promote skin health by targeting aging at the molecular level.                                             Carolina Holds a Ph.D. in stem cell biology and tissue engineering and is an alumnus of IndieBio, a renowned biotech accelerator, and has been an active voice in the longevity field, pioneering age reversal skin research with OneSkin. In this episode we dig into: The science behind OneSkin & their new products Reversing skin aging for longevity Peptides & senescent cells New research on fertility & hair loss And much more! Check out the full podcast here: https://longevity-and-lifestyle.com/podcast-105-carolina-reis Follow Guest On: Instagram Website Facebook LinkedIn Twitter Follow Claudia On: Instagram Facebook YouTube LinkedIn Twitter Past guests on The Longevity & Lifestyle Podcast include Dr. David Perlmutter, Dr. Amy Killen, Sergey Young, Dr. Dale Bredesen, Dr. Kristen Willeumier, Dr. Louise Newson, Dr. Kien Vuu, Dr. Carolina Reis, Marie Diamond, Nikolina Lauc, John Gray, Morri Chowaiki, Leslie Kenny, Maziar Brumand, Fiona O'Donnell-McCarthy, Mohamed Massaquoi, Nick Potter, Dr. Pamela Kryskow, Dr. Julia Mirer, Dr. Julia Jones, Dr. Austin Perlmutter, Dr. Richard Johnson, Isabella Channing, Dina Burkitbayeva, Raewyn Guerrero, Mario Chamorro, Mariko Bangerter, Harris Khan, Juraj Kocar, Dr. Stephanie Manson Brown, Dr. Mohammed Enayat, Dr. Molly Maloof, Helen Reavey, Elena Letyagina, Dana Frost, Niall Breslin, Dr. Limor Goren, Larisa Petrini, Leighanne Champion, Mike Bennet, Dr. Louise Swartswalter, Dr. Joseph Antoun, Patrick McKeown, John Gray, Brooke Schnittman, Natalia Spierings, Adele Wimsett and many more!   If you enjoyed the podcast episode, please consider leaving a short review! It takes a few seconds but means the world to me to get the best guests and content for you and I love reading your reviews! Thank you!

A conversation with Martin Stübler, the founder of BioFluff, which develops 100% plant-based fur -an alternative to animal and plastic fur for the fashion industry. He talks about BioFluff's story, the opportunities and challenges of the plant-based market for fashion and other industries, his upcoming projects and what the future of sustainable fashion looks like. Martin has made it his lifelong mission to create unconventional products with fewer natural resources, and his degrees in Agriculture, Biotechnology, and Bio-economics helped him drive that road. His nomination for the LVMH innovation award, fashion for change competition and the IndieBio program, and various other government prizes established him as an expert in the biomaterials field as well as a passionate ambassador for plant-based products.  https://bio-fluff.com/

Welcome to The Startup Tank Climate Investor Pitch Show presented by 4WARD.VC, the ultimate startup investor pitch contest where top climate tech founders pitch to a panel of VCs looking to fund world-positive cleantech & sustainability startups looking to move the world forward. If you've ever wanted a chance to pitch your company or get in front of VCs and angel investors, now is your time to shine. https://thestartuptank.com/apply Presenting Companies: - Viritech: Improving the efficiency and reducing the weight of hydrogen fuel-celled powertrains - WAS Company: Developing industrial plastic waste into materials for building construction - New Day Hydrogen: Fossil free hydrogen fuel micro-hubs - GPI Innovations: Innovative design to reduce ship and aircraft fuel consumption 15% - eevie: The employee engagement climate platform to make corporates more climate-friendly. Today's Investor Panelists Include: - Shaneez Mohinani @ Pear VC - Parikshit Sharma @ IndieBio The Startup Tank is brought to you by 4WARD.VC's "Partner in Crime" Climate Accelerator program and Climate Investor Syndicate 4WARD.VC's “Partner in Crime” Climate Accelerator is disrupting the outdated venture industry with the world's most hands-on, sales & traction-focused accelerator for elite early stage climate companies led by CRAZY ASS, world class climate founders tackling MASSIVE problems in areas including Food & Agriculture, Construction & Manufacturing, Commerce & Circularity, Recycling & Waste Reduction, Energy & Renewables, Transportation & Mobility for more info and to apply, please visit: http://4ward.vc/accelerator 4WARD.VC's Climate Investor Syndicate also allow accredited investors to participate in the post-program investments in our portfolio companies. For more information on 4WARD.VC's accelerator and accredited investor syndicate, please visit: https://4WARD.VC -- BONUS: Free 850+ Climate VC & Accelerator Database 4WARD.VC made a searchable index of 750 climate, sustainability and impact investors, LPs, incubators, accelerator programs and angel investor groups worldwide. Filter climate tech VCs by stage, sector, geography & check size to find your ideal investor and/or co investors! https://4ward.vc/VCdatabase -- About The Startup Tank Climate Investor Pitch Show Welcome to The Startup Tank Climate Investor Pitch Show presented by 4WARD.VC, the ultimate startup investor pitch contest where top climate tech founders pitch to a panel of VCs looking to fund world-positive #cleantech & #sustainability startups looking to move the world forward. If you're combating climate change by building the next sustainable development (SDG) superstar or circular economy unicorn and looking to fundraise from top tier VCs and angel investors, you've come to the right place Founders apply: http://thestartuptank.com Investors apply: http://4WARD.VC

Meat, be in hotdogs, hamburgers or bacon in BLT sandwiches, has long functioned as the centrepiece of the American diet. In recent years, due to the growing awareness of health and environmental impacts of meat, consumers are starting to seek out alternatives for meat. Alternative meat is a broad category, plant-based meat will be one of the brilliant options that encourage consumers to reduce their meat intake. By delivering the same flavour and texture of real meat to mimic the experience of eating meat as closely as possible. Lypid, founded by two Cornell Taiwanese scientists, has use its proprietary formula and processing method to develop vegan fats that accurately mimic the texture, mouthfeel, transfer of flavour, and cooking behaviour of animal fats. In 2021, Lypid has been selected into SOSV's indieBio and raised 4 millions funding. A year later, they announced a partnership with Louisa Coffee, one of the largest coffee brands in Taiwan with 500+ stores, to serve their plant-based burgers. In this episode of Startup Island Taiwan Podcast, you will find out: ☛ Foodtech can be really important and critical for climate change? ☛ Michelle and JenYu first start the idea when they were neighbour in Cornell ☛ Fat is the key to make vegan meat taste like real meat ☛ Plant-based meat is actually healthy ☛ The goal for Lypid is not replacing the animal meat but provide a new option for consumer to choose Host: Asianometry, Deep tech channel with 447k followers, still growing Guest: Michelle Lee, Co-founders of Lypid & Jen Yu Huang, Co-founders of Lypid Powered by Startup Island TAIWAN Directed by National Development Council

This week's episode features Alessandra Zonari, Ph.D., Co-Founder and Chief Scientific Officer of ONE SKIN, an innovative skincare company that addresses skin health at the molecular level, targeting the root causes of aging so skin functions, feels, and looks younger.  Listeners get a special offer when they go to OneSkin.co:  Enter SCIENCE15 to get a 15% discount on your ONE SKIN purchase. On this week's show, we discuss a range of issues related to entrepreneurship and the science of skin care, including: What initially sparked Alessandra's interest in science:  03:19 Alessandra Zonari, Ph.D.: On all the news, when I was seeing the news, they were cloning Dolly, the sheep. They were cloning the first mammal, animal. And that I thought to myself, Oh my God, maybe I can one day clone my family and they will always be around. I will not be, I don't need to be afraid of losing one day my dad. I can bring back my grandfather. And that sparked me the idea of going into science and this whole knowledge of not liking to see losing others for diseases was what started bringing me. Maybe one day I can find the cure of a disease. Maybe one day I can work with something that will help me not lose my family. That was the first when I was still very young that we were made me science and as I was studying all my biology teachers, I was always very interested in cell biology. And that's why I decided in college to continue researching and studying biology. Alessandra's career journey, including when she decided she wanted to be an entrepreneur:  06:08 Alessandra Zonari, Ph.D.: When I went to college, I had this notion that I wanted to do science, but it was still very obscure how I will get there, if I would really be able to bring something into reality and get some of the science. In college, I was already focused on research that was translational. When I started college, I was already completely passionate about the idea of working with stem cells and the potential of stem cells to differentiate into any cell type of your body and be able to regenerate different tissues. So when I was in college, I looked for an internship in a lab that was researching stem cells. I knew that I wanted to translate. I didn't know how would be the path that one day I would start the company, that was not clear. I knew that I needed to learn how to do science, so I would need to do a master and a PhD. Even when I finished my PhD, I had not a clear idea. I still went for a postdoc in Portugal where I continue learning and learning different biomaterials to use different ways of associating with stem cells to promote wound healing. And at that point, when I was already in my postdoc that I was doing research for ready eight years in total, if I count when I started my internship, my master, my PhD, I started to get a little bit frustrated. I was doing a lot of good research. I was learning a lot and I was being involved in different projects that was all very challenging, was teaching me a lot, but I was not seeing the next phase. What I would do next, how I will fulfill that desire of seeing science being translated. So still in Portugal, I tried to start a startup there that was using stem cells, but cell therapy, it's very regulated. It's hard to go to humans. So I have some, had some colleagues that were veterinarians. So together we start the company that would provide stem cell treatment for dogs, cat and horses. But we didn't know what we were doing. And at the beginning was everything super hard to get to the path of what was a startup and how you get funds and how you create this product. So basically we started the idea, but that never went very far, but I was already okay, I want to translate. And then eventually my friends from Brazil that also did PhD in the same lab that me, Carolina had just moved to San Francisco to join an accelerator program where they were also wanting to translate some of the research into a product or into a company. And it was interesting because then she was starting this year, I was starting that company in Portugal, getting a little bit frustrated. And then after the program, they decided they would be focusing this new company on skin research. And then eventually she called me and she said to me, Alessandra, I'm here in San Francisco. I have some ideas on understanding skin aging and validating efficacy of product. And I cannot think of anyone better than you to come to join this project. We had no guarantee of what we were doing or where we would go, but there was a new opportunity there for me. And I just said, okay, I'm packing, I'm moving to the US. Let's start this company. Let's see where we can go. Alessandra's research and ONE SKIN's scientific advancements in skin care: 13:41 Alessandra Zonari, Ph.D.: I can even make the connection of my PhD and the company, how we started. And it's interesting because when you start a company, you need to be open-minded. Things change. I was doing this research on skin regeneration, building 3D skin models. And the goal really was to promote a better wound healing. But in that process, I learned how to culture skin cells. I learned how to build 3D skin models. When I was on my postdoc also, I was helping on another project that was doing high throughput screening of micro RNAs. So I started learning high throughput screening as well. And when I was learning all those skills, I had no idea that eventually I would use those skills in my own startup. But what I always tell myself and I tell others is it doesn't matter, even if you are like completely happy or unhappy with what you're doing at the moment, if you are lost a little bit of what path you would take, show up every day and try your best and learn what you have to learn because eventually what you learn, you can use later on. So when I was there in Portugal, a little bit frustrated, still doing research and not seeing how I would translate that to research, I was still showing up at the lab and learning things, new things. And those skills that I was learning there, eventually they were the ones they needed to one skin. When I came to One Skin, the first idea when Carolina called me was let's build 3D skin models to understand the aging process and validate products that are on the market. So we had already the knowledge of building 3D models, but sometimes we use very young skins because it's easier to build 3D models of skin using young cells. So the goal now was, okay, let's understand the aging process because the products that are aimed to promote rejuvenation, they will be applied on a more mature skin. So we need to see the effect on this skin and what's the difference. So we started building this platform. One Skin then, just to go back a little bit, One Skin has always has the mission of target root causes of aging to promote skin health. So we are really looking to ways that we can connect the health of your skin with your overall health, promote a younger state of your skin, and that will result in a better appearance as well as you bring a product that's cosmetic, but with the goal that will also help your whole body to be aging better. So we started with this platform. Alessandra's approach to science communication as a bilingual scientist: 21:13 Alessandra Zonari, Ph.D.: I would say that's still a challenge. It is super hard because especially when you're passionate as I am about the science, I always tend to go into too many details and then when we start to having to communicate this to others, at the beginning I was going very deep on the details and then I was seeing on people's face that they were not understanding what I was saying. So the first thing I feel to start developing that skill is just talk to people that have no science background. That they understand what you're saying. If they're not understanding, you need to clarify your message. And then it was hard for me because when I simplified the message and I don't give all the details, it feels that I'm not giving all the science that is there. I always had that challenge with me because I wanted to explain more, but at the end, we need first to educate and have the interest of people.  So we need to get simple, even though I don't say all the science, I need to be able to show the difference. For instance, we have developed an algorithm that in the beginning, I would say that measures epigenetic changes inside the cell through methylation profile, and it's able to determine and correlate with the chronological age of the skin, and I say that no one understands. But if I just tell you that we have an algorithm that's able to measure the real biological age of your DNA, and then I can tell you by measuring the biological age of a product that's really rejuvenating, reducing the biological age of the skin. Now people can understand and get interested about it. And a lot of that comes from speaking and talking with non-scientists. We have several documents where we write what is the science and now let's cut all this "epigenetic methylation" and let's simplify the message. And we focus a lot on educational content on our Instagram and all on our website. There is a blog section where we talk a lot about science and I started and I still struggle a little bit with that. I'm still in the learning process, but we are always trying the best. 23:38 Mark Bayer: Right. And it is difficult. It's really hard to do. There's so much information and it is an iterative process. So the more you're doing this, the better you're getting at it. And then of course you're seeing the reaction of people. They actually do get what you're talking about rather than when you're talking, using these scientific terms and they're just bewildered because it's the first time they're hearing that. 25:13Mark Bayer: really interesting and so true. Let me ask you, many listeners are interested in entrepreneurship, but they don't really have an idea of what it's all about, whether it's to start a company or work for a startup and understanding that there is no typical day in your work experience, I'm wondering if you could share some of the mainstays of your work schedule, things that you often see on your calendar as things that you need to do just to give listeners a sense about what it is to work for a startup or a startup company. An insider's description of life as an enterpreneur at a start-up  25:43 Alessandra Zonari, Ph.D.: For both sides, if you're working for a startup or if you're starting your company, you need to know that you will be wearing several hats. But to be very honest, in the very beginning, a lot of the daily basic tasks will be very similar to what you were doing in the academia. You will still be working in a lab doing the research. So the part of research, it's very similar to the academia. What it adds, it adds other layers. So the research usually in the startup environment is more focused. So you have very clear objectives that you need to respond. You're doing experiments, looking to proof of concept and looking more objectively while when you're in academia, if you do one experiment and something show up, you just start digging and you just go to a completely different project and that's not a problem because you're just reaching and learning. So this is a big difference. But on the beginning, the daily base inside the research lab, it's very similar. What it changed then, like when you're starting a company, is that you have other tasks as well. Pitching your company all the time to investors. You're also hiring new employees. In the beginning, for the first three years, ONE SKIN was only scientists. We were seven scientists doing research with this platform. When we start moving to create the product and create the brand, then now other pieces start to show up. I needed to start thinking about the communication, the content that we are creating to blogs or even Instagram, talking more to investors. And then eventually when you go to having a product in the market, you have operational sales and marketing and all different things. Today, as a chief scientific officer at ONE SKIN, I still lead the science that we are researching, the new research, the development of new products that we are doing at the company. I also do a lot of collaboration with the universities that are researching some of our active peptides that we have to other applications beyond the skin. I do a lot of work reviewing documents that share the data that we get in the lab to the marketing side, so it's accurate and being sure that anything that's going out there is very accurate on the science side. I lead with hiring process and also other fun things as well, because we have products, we are deciding which packaging will be for the new products. So we have meetings with the designers. And for instance, today, some of the things that I will be doing, I'm recording this podcast now. Then I need to analyze some data of a clinical study that we are running. I need to oversee the experiments that was run this week and check some that we'll do next week, need to go over some documents of scientific communication and also using one of the packages and some things that are going for our next product, so it goes a little bit around several things you need just when you're in a startup, multitasking, it will be also very important to be able to wear different hats and being creative because not always you have funds to do everything on the perfect way. So we need to be very creative on how we can be different, how we can even do our research with the resource that we have available. A special disount offer for listeners of When Science Speaks 30:35 Alessandra Zonari, Ph.D.: We are very excited to launch it. So it's a product that has as an active ingredient the peptide that we discovered and developed here in the lab. And it was specifically designed for the skin of your eye region. So we received skin samples from the eyelid, leftover of plastic surgery. So we were using very specific eyelid skin to be testing and validating this formula to promote a better appearance, a more firm skin for a specific for this eye area. And we're very excited. We optimized the formula using our platform as well. We use our platform to test all the active ingredients that goes together with our peptide and in the final formula to ensure that there is no toxicity. There's no side effects that can be used in sensitive skin. And then we were able to do this specifically using skin from the eye area, which is something very new and unique. And this product is coming up at the end of this month. So we are very excited about it. 31:40 Mark Bayer: All right. So cool. Yeah. Listeners look out for that and also the promotional code that you'll have as well. Alessandra's advice for listeners thinking about getting involved in startups  32:26 Alessandra Zonari, Ph.D.: Yeah, sure. To make the jump going out of academia and jumping to start a company, you have two options. You can either join an early stage startup, or if you have an idea, or if you have already research coming from your PhD, you can start your own company. What I would say it's what we did a little bit was for starting to find accelerator programs that can help you on the start point. So we joined IndieBio - it's an accelerator program specifically for biotech companies, specific for scientists that want to become entrepreneurs. So this is very helpful because there are mentorships. You meet different founders that are on the same stage as you and you start creating this network. And a lot of times you learn with other founders how to do things, how to get off the ground. My advice would be to try to find an accelerator program. Try to find people that complement your skills, that are also passionate about what you're looking or trying to solve. And there will be ups and downs. Don't give up on the first down and always remember that you never fail because you're always learning something and what you learn, no one will take from you. So you will use this next. So just do the best and good luck in any journey that anyone decides. Resources mentioned in the episode   Special discount code for When Science Speaks listeners: 15 percent off your purchase of any of the skin treatments at OneSkin.co    Use SCIENCE15 at checkout  

In the first episode of our food and beverage sprint, we talk to Po Bronson, Managing Director of IndieBio, the world's leading biotechnology accelerator. Join us as we explore the world of alternative foods and the investments behind them. Listen to learn about the importance of how startups deliver their product, the necessity of technical knowledge in the food industry, and the science behind what makes the food we eat tasty! Interested in learning more about Po and IndieBio? Twitter: @pobronson Website: IndieBio --- Support this podcast: https://podcasters.spotify.com/pod/show/nyu-svs/support

Sonia Arrison, 100+ CapitalSonia Arrison is a longevity investor via her company 100+ Capital, a women's investor group called Portfolia, and advises BioVerge here in Silicon Valley. She also spends time helping the Alliance for Longevity Initiatives (A4LI). She is helping A4LI streamline the political processes for advancing longevity research and therapies.When Sonia first moved to California from Canada in 1999, she helped educate congresspeople about the internet and digital technologies. She soon became interested in nanotechnology, and by extension the Foresight Institute. Her interests then turned toward longevity, and she began writing articles here and there about the topic. Peter Thiel convinced her to turn those articles into a book – “100+: how the coming age of longevity will change everything”.She was later pulled into a project with Ryan Bethencourt at IndieBio, becoming his first investor. That catalyzed her role as an angel investor in the longevity biotech space. Around that same time, she was involved in Singularity University. She realized how investable the longevity space had become, and rather than write yet another book she became a major investor in the longevity space.Session summary: Career Counseling with Sonia Arrison - Foresight InstituteThe Foresight Institute is a research organization and non-profit that supports the beneficial development of high-impact technologies. Since our founding in 1987 on a vision of guiding powerful technologies, we have continued to evolve into a many-armed organization that focuses on several fields of science and technology that are too ambitious for legacy institutions to support.Allison Duettmann is the president and CEO of Foresight Institute. She directs the Intelligent Cooperation, Molecular Machines, Biotech & Health Extension, Neurotech, and Space Programs, Fellowships, Prizes, and Tech Trees, and shares this work with the public. She founded Existentialhope.com, co-edited Superintelligence: Coordination & Strategy, co-authored Gaming the Future, and co-initiated The Longevity Prize. Apply to Foresight's virtual salons and in person workshops here!We are entirely funded by your donations. If you enjoy what we do please consider donating through our donation page.Visit our website for more content, or join us here:TwitterFacebookLinkedInEvery word ever spoken on this podcast is now AI-searchable using Fathom.fm, a search engine for podcasts.  Hosted on Acast. See acast.com/privacy for more information.

WTF is going on with alternative protein? To find out, we decided to catch up with one of our favorite people in future food, Indiebio's Po Bronson. Po went from being one of the early chroniclers of the dotcom boom via his novels and nonfiction titles to leading one of the most active investors and accelerators in the future of food in IndieBio, and in this podcast, we talk about his journey and how he become a VC. We also talk about the current struggles facing certain sectors of alt protein and where he sees things going. 

Benjamin Joffe is a Partner at SOSV, a global deep tech fund with 1000 portfolio companies and $1.3B AUM. They focus on early-stage planetary and human health. They invest the very first checks at pre-seed via the startup programs HAX (hard tech), IndieBio (biology), Orbit (frontier markets), and dlab (blockchain). Benjamin started in an investing role in the HAX program in Shenzhen (invested in Opentrons, now a unicorn), and later chose to work in a non-investing role across the portfolio.He's been an active angel investor, super speaker, and moderator in hundreds of events globally, and he's now the curator at SOSV Climate Tech Summit which happens virtually every year, generally in October.Listen and LearnDescribe SOSV, ticket size, geography, and history (2:18)Who backs SOSV today? (4:03)How is SOSV structured today? (5:00)Why did you decide to invest in climate? (6:35)SOSV Climate Tech summit (8:07)Do you see a better balance between the US, EU, and China in Climate Tech going forward? (10:30)Have you seen more climate funds start outside of the US this year? (12:58)What is the interaction between the EU and China in ClimateTech? (14:13)Has the climate conversation matured in Asia? (16:06)What is your role and how do you structure your investment scope? (18:40)Is building a personal brand a must as a fund? (20:22)Would you advise new funds to be more visible? (21:59)Is building a personal brand the best way to access the best deals? (25:01)What drives maximum return: software or hardware? (26:37)What is the key to differentiation? (28:13)Rapid fire round (30:08)Where would you advise people to look for jobs within climate? (35:01)Show LinksBenjamin Joffe LinkedIn profileSOSV HAX - Hard Tech Venture CapitalIndieBioOrbit StartupsdlabSOSV Climate Tech SummitVoyagers community eventClimate Tech VCWork on climate Land Your Dream Job in Climate Tech by Yoann Berno

In der Rubrik “Investments & Exits” begrüßen wir heute Tina Dreimann, Co-Founder von better ventures. Tina hat die News von Patagonia, der neue Fonds von Junction und die Finanzierungsrunden von NeoCarbon und Prolific Machines analysiert: Der 83-jährige Patagonia-Gründer Yvon Chouinard und dessen Familie haben die etwa drei Milliarden US-Dollar schwere Firma Patagonia komplett einer Treuhandgesellschaft bzw. einer Non-Profit-Organisation geschenkt. Chouinard hat zusammen mit seiner Frau und seinen beiden Kindern sowie einem Team von Anwälten eine Struktur geschaffen, die es Patagonia ermöglicht, weiterhin als gewinnorientiertes Unternehmen zu operieren, dessen Erlöse in den Umweltschutz fließen. „Ab sofort ist die Erde unser einziger Aktionär“, teilte das Unternehmen mit. Mit dem Ziel, eine entscheidende Rolle bei der Energiewende in Europa zu spielen, wurde ein neues, wirkungsorientiertes Unternehmen gegründet: Junction. Der Fonds plant, insgesamt 100 Millionen Euro in Startups für grüne Energietechnologien in ganz Europa zu investieren, und hat gerade einen ersten Betrag von 75 Millionen Euro geschlossen. Zu den Köpfen hinter dem Projekt gehören der Mitbegründer von REstore, Pieter-Jan Mermans, der frühere Inven-Partner Vincent Gregoir, der Gründer des Ökostromanbieters Lampiris, Bruno Vanderschueren, und Dirk Dewals, der zuvor im Vorstand des Private-Equity-Unternehmens GIMV tätig war. NeoCarbon, ein in Berlin ansässiges Tech-Startup, das Kühltürme nachrüstet, um Kohlendioxid aus der Atmosphäre zu entfernen, gab heute bekannt, dass es 1,25 Millionen Euro eingeworben hat. Die Finanzierungsrunde wird von PropTech1 und Speedinvest gemeinsam angeführt, mit Beteiligung von Antler und Angel-Investoren. An der Runde des Direct Air Capture (DAC) Unternehmen beteiligten sich auch mehrere hochkarätige, auf ClimateTech spezialisierte Angel-Investoren wie die Foundeirn von Planetly Anna Alex, Stefano Bernardi und Matthias Ernst. Das frische Kapital wird die Skalierung der Technologie von NeoCarbon vom Laborstatus hin zu einem kommerziellen Pilotprojekt durch die Erweiterung des Ingenieurteams ermöglichen. Prolific Machines, ein in San Francisco, Kalifornien, ansässiges BioTech, hat 42 Millionen US-Dollar in einer Seed- und Series-A-Finanzierung erhalten. Die erste Runde von Prolific wurde Ende 2020 abgeschlossen, als SOSV's IndieBio die Pre-Seed-Runde anführte. Die Seed-Runde wurde von Arvind Gupta von Mayfield geleitet. Die Series A wurde von Breakthrough Energy Ventures geleitet, mit Beteiligung von David Adelman, Mark Cuban, The Kraft Group, David Rubenstein, Michael Rubin, Breyer Capital, The SALT Fund, Purple Orange Ventures, Fred Blackford, Jake Poliskin, Baruch Future Ventures, David Adelman, Mark Cuban, The Kraft Group, Kevin Love, Tobias Harris, Meek Mill, Ciara & Russell Wilson, Emily Ratajkowski, Maverick Carter, Sean Feeney, Michael Schulson, Mark Bucher, und RJ Melman. Das von CEO Dr. Deniz Kent geleitete Unternehmen Prolific Machines ist ein Hersteller von biologischen Produkten, der sich zunächst auf gezüchtetes Fleisch konzentriert, das zellagnostisch ist. Patagonia hat kein Bock das Leute ihre Jacke kaufen: https://eu.patagonia.com/de/de/story-18615.html Infos der Werbepartner: ROQ: Gehe jetzt auf roq.tech/daily und erhalte die komplette Plattform 3 Monate lang for free.

Arvind Gupta is a genetic engineer and venture capitalist whose approach to investment is driven by trying to better the planet, yet without the use of moral arguments and platforms. Instead, his approach to business draws on his personal experience with mortality and behavioral insights into how people can and cannot be convinced of a need for change. Arvind is also an accomplished rock climber, BASE jumper, and mixed martial artist.Living Philosophy is brought to you by Philosophy2u.com.Host:Dr Todd MeiSponsors:Philosophy2u.comHillary Hutchinson, Career and Change Coach at Transitioning Your LifeHermeneutics in Real LifeGeoffrey Moore, author of The Infinite Staircase     Links Related to this Episode:Arvind Gupta (LinkedIn)IndieBioMayfieldAlbert Camus (1913-1960, Wikipedia)Viktor Frankl, Man's Search for Meaning (Good Reads)Decoding the World, Arvind Gupta & Po Bronson (Good Reads)Uma Valeti (Good Food Institute)Upside FoodsEric Beinhocker, The Origin of Wealth (Good Reads)Photo: IndieBioMusic: www.bensound.com

Hoy estoy con Ricky Cassini, Co-fundador y CEO de Michroma, una empresa de biotecnología que desarrolla colorantes naturales a base de hongos para la industria de alimentos. Hablamos de como pasó de visitar Silicon Valley como universitario a ir como CEO solo 3 años después para entrar a la mejor aceleradora de biotecnología del mundo, también nos platica sobre sus startups anteriores y nos da tips sobre cómo saber cuando dejar un proyecto y muy buenas recomendaciones para emprendedores que se quieren enfocar en la biotecnología. No dejes de escuchar esta súper entrevista.Donde quiera que estés no olvides dejarnos una reseña Libros mencionados:Decoding the world - Po Bronson & Arvin Gupta Sobre el invitado:Conecta con Ricky en LinkedinMichroma | WebsiteMichroma | Linkedin Follow Us:NewsletterEscribe una ReseñaEncuesta de AudienciaTikTokInstagramTwitterLinkedinWeb 

In this episode of Startup Hustle, Steven Hoffman and Arvind Gupta discuss current Silicon Valley Investment trends and anticipated future trends. Arvind is a partner at Mayfield Fund and Venture Advisor at IndieBio. As the Founder of IndieBio in 2014, Arvind redefined the pace and possibilities of early-stage biotech, investing in over 136 companies in five years. Find Startup Hustle Everywhere: https://linktr.ee/startuphustle This episode is sponsored by Full Scale: https://fullscale.io/ Learn more about Founder Space: https://www.foundersspace.com/ Learn more about Mayfield: https://www.mayfield.com/       See omnystudio.com/listener for privacy information.

“The more I looked into it, the more broken the pet food industry was.  It accounts for 25-30% of meat consumed in the U.S...it just makes no sense because we can make protein out of yeast, out of fungi, out of plants...and so I'm like, somebody needs to start this company.”  -Ryan Bethencourt, Co-founder and CEO of Wild Earth.  Ryan Bethencourt (@ryanbethencourt) is a co-founder and CEO at Wild Earth (@wildearthpets), bringing years of experience in leading, building and advising high-growth food and biotechnology companies. Ryan is a biotech entrepreneur, investor, and one of the founders of the biohacker movement. He's a co-founder, former Program Director, and Venture Partner at IndieBio (@indbio) and has invested in over 110 early stage biotech startups and served as the head of life sciences at the XPRIZE Foundation (@xprize). As an ethical vegan, Ryan is passionate about the future of biology as a technology, applied across all industries to solve some of humanity's most intractable problems. Ryan fosters dogs for Rocket Dog Rescue and is passionate about mindfulness, meditation, and mentoring. Enjoy the show!Climate Tech Cocktails (CTC) is a bootstrapped project.  Interested in sponsoring?  Please reach out to m@climatetechcocktails.comFor show notes and past guests, please visit the CTC Substack.Follow CTC:TwitterInstagramFacebook

Is climate change opening the floodgates of the germ zoo? Are Silicon Valley investors understanding and accepting climate change? In this episode, Zeeshan chats with Arvind Gupta and Po Bronson about their book, Decoding The World, where they try and decode the real cause of the pandemic, climate change, iGEM and SynBio & Silicon Valley!Arvind is the founder and a venture advisor at IndieBio, which is the world's first and leading accelerator dedicated to startups in biology to solve the world's problems. As founder, Arvind has redefined the possibilities of early stage biotech, investing in over 136 companies over five years and growing the IndieBio portfolio into billions of dollars in value. His current role is at the global VC firm, Mayfield, where he co-leads the engineering biology practice whose mission is to invest in science based companies that could change history. Po Bronson was a finance and tech journalist covering Silicon Valley for Wired, The New York Times Magazine, and an op-ed contributor for The Wall Street Journal. His science journalism has been honored with nine national awards, and he is the author of seven bestselling books that are available in 28 languages worldwide. Po is currently the Managing Director of IndieBio and General Partner at SOSV, the venture firm that backs IndieBio.

Jun Axup is the Chief Science Officer and Partner at IndieBio, the world's leading biotech startup accelerator. Focused on turning scientists into entrepreneurs, IndieBio has funded and helped build 100+ biotech companies spanning the future of food/agriculture, consumer biotech, computational biology, digital health, therapeutics, medical devices, neurotech, and regenerative medicine. In this episode, Jun shares her journey from scientist to entrepreneur to VC, reveals the moonshot projects underway at IndieBio, and reflects on VC in the post-COVID era. --- Support this podcast: https://anchor.fm/theia-hc/support

Dr. Carolina Reis Oliveira is the Co-Founder and CEO of OneSkin, a biotech company developing solutions to target skin aging at the molecular level and extend the healthy years of life.  Carolina is leading the development of the first anti-senescence topical product designed to promote skin health, which can be bought from their website OneSkin.co.  She is a co-inventor of 3 patents, co-author of numerous scientific publications, and has been an advocate of skin health in the longevity community.   Carolina holds a biochemistry degree and a Ph.D. in stem cell biology and is an alumnus of IndieBio, the world's leading biotechnology accelerator. She relocated to Silicon Valley from Latin America in 2016 to co-found One Skin.  In this episode, we talk about:  the importance and correlation of skin inflammation and chronic disease, The surprising truth about retinol, Using the epigenetic profile of our tissues as a marker to understand if an intervention is really improving our skin on the cellular and molecular level, Successful morning routines, The importance of a positive attitude towards life, Using key peptide molecules to eliminate senescent cells, making you look and feel 10 years younger, The science behind OneSkin,  And understanding skin longevity, trends and much more!  Please enjoy! --- If you enjoyed the podcast, I would love to hear from you so please leave a review on Apple Podcasts/iTunes! It takes less than a minute but helps me to know what you liked, and what you would like to hear more of. Thanks so much!

Arvind Gupta, founder of IndieBio and co-lead of the engineering biology practice at the venture capital firm Mayfield, and Po Bronson, author and managing director and partner at IndieBio, sit down with Neil to discuss their new book Decoding the World, IndieBio, and the future of biotech.

We discussed a few things including:1. How SOSV's portfolio startups are responding to crisis and the new IndieBio Coronavirus Initiative which seeks up to 8 startups to receive a minimum of $250k each.  2. State of investing globally and how the coronavirus is affecting funding activity.3. Advice for entrepreneurs in these unprecedented and challenging times.4. SOSV's new IndieBio accelerator which is launching in NYC this spring.Sean is the founder and managing partner of SOSV which has invested in over 900 startups, investing about $65 million per year in the 150 startups that go through its global accelerators annually which help create over $2 billion in new market capitalization every year. Recognized in 2017 as the world's #1 most active global early stage investor and the #2 most active global seed investor*, SOSV's accelerator model takes a small initial stake in startups and provides a framework and community where startups get further and faster than they could on their own.SOSV runs the world's most active accelerators in hardware (HAX), life sciences (IndieBio/RebelBio), disruptive food (Food-X), and Asia cross-border startups (Chinaccelerator/MOX). As of 2019, SOSV is in the top 6% of venture capitalists globally based on return an investment (returns over 20 years average 38% Net IRR).O'Sullivan's first company, MapInfo, grew to a $200 million public company with over 1,000 employees, and popularized street mapping on computers. His first internet company, NetCentric, developed many concepts in internet computing, and he is credited as the co-creator of the term “cloud computing”. Sean founded JumpStart International, a leading humanitarian organization in conflict zones, in the 2000s, where he oversaw over 3,500 staff at the height of the organization during the Iraq conflict.O'Sullivan received his Bachelors of Science in Electrical Engineering from Rensselaer Polytechnic Institute and a Masters of Fine Arts in Film Production from the University of Southern California. He is also a primary supporter of such organizations such as Coderdojo (a global network of coding clubs that 50,000 kids attend every week) and Khan Academy (used by 15 million students to learn every month). He's on the board of Khan Academy, I-ASC, and a number of private companies.

Leonardo Alvarez primero logró llegar de Chile a Silicon Valley con su startup de biotecnología Protera. Luego de pasar por la aceleradora especializada IndieBio, se lleva la empresa a Francia, con 5.5 millones de dólares de inversión y un lugar en la aceleradora más grande del mundo. Nos cuenta cómo le sacó el jugo a Silicon Valley para dar el salto a París. SÚMATE A LA COMUNIDAD TERCA No estaríamos acá sin las personas que aportan unos dólares por mes en Patreon y se conectan por chat y videoconferencia. Súmate aquí. RECOMIÉNDANOS Escribe una reseña en Apple Podcasts. ESTAMOS EN ELVALLEDELOSTERCOS.COM Y en Twitter, Facebook y LinkedIn. MÚSICA Pablo Calvi y su banda Demon Verlaine. EDICIÓN MULTIMEDIA Mariano Graglia LOS #TERCOS SOMOS Fernando Franco y Diego Graglia ¡TE QUEREMOS! #startups #emprendedores #latinos #SiliconValley #innovación #inspiración

Today, Chris sits down with Ryan Bethencourt, CEO of Wild Earth Inc, to talk about science fiction, biohacking, the birth of biotech and disrupting one of the oldest industries on the planet. Chris also talks grill etiquette, retreats, and tells you to eat a GMO salad. You can follow Ryan on Twitter and Instagram at @RyanBethencourt; Wild Earth can be found at @wildearthpetsFor more cutting edge biotech companies, check out Indiebio, the biotech accelerator that Ryan co-founded.If you want to get inspired by some science fiction, here's a list to start working your way through.From HBR: Making Empathy Central to Your Company CultureFrom Inc: United's Latest DisasterFrom Med News Today: More Evidence You Should Eat BetterFinally, Ryan referenced Ethan Perlstein, another person you might want to follow in this space. Check him on Twitter at: @eperlste

This is a rerun episode after one month of no publishing. As mentioned in the last episode, I changed the publishing frequency to monthly. Why am I doing now a re-release of a past episode? Perhaps you've seen the recent report by HAX, the hardware accelerator based in Shenzhen, China and in San Francisco: their first hardware report in 2018. In the report they mentioned the importance of a great team when building a company and immediately this past episode with Alan Clayton came up in my mind, who's the person assessing hardware startup teams' healths. Since this is a very important topic, I wanted to bring it in focus again by re-releasing this episode. Alan has been working for SOSV, the Venture Capital company, since its beginnings in 2010. You might know as SOSV as it's the world's top hardware VC. They're special also in another aspect as unlike other VCs, SOSV runs accelerator programs, such as HAX, HAX Growth, RebelBio, IndieBio, Food-X, Chinaaccelerator, MOX. They are understandably very tech-focused and Alan Clayton is the person who understands people. This means he makes sure you have the right team to deliver the right results as otherwise things can and if they can, then they will go wrong. The question we addressed in this episode is: how can you maximize your success with your team? You can learn in this episode about successful team's composition, the Herrmann Brain Dominance Instrument (HBDI) for testing what areas the team covers, and also how this knowledge can help you pitch your idea better. So in essence we'll go deeper than just talking about the left and right brain thinking. Enjoy this episode! Raw transcript is available at: https://www.thehardwareentrepreneur.com Show highlights can be seen below: Do you use your brain's full capacity? - [3:27] What SOSV stands for and Alan's role in the company – [6:38] Who is Ned Herrmann and how his work is helping startups work more effectively? – [7:48] At which phase of the startup process you will most surely need Alan? - [9:17] How does a startup founders' assessment unfold? - [12:42] Which type of intelligence are you - Captain Kirk, Doctor Spock, Scotty the engineer or Doctor Bones? - [15:04] How to avoid conflicts and benefit from the team diversity at the early stages of a startup? - [21:38] What are the major success factors for hardware startups? - [24:58] What set of skills does a hardware startup CEO need to develop? - [27:20] A Star Trek crash course on pitching - [30:30] If you could time travel and go back in time, what notes would you give yourself? – [34:54] Which book had the biggest impact on his career? – [35:39] Some cultural differences that Alan observed throughout his career – [36:46] Alan's recipe for a good start of the day - [38:55] What is the best way to reach Alan? – [42:20]

In this episode I interview Ryan Bethencourt, a vegan biotech entrepreneur, investor, and one of the founders of the biohacker movement, in Los Angeles. Growing up in inner-city Miami, Ryan's imagination was fueled by science fiction and as an adult he's focused on using science and technology to solve some of humanity's most intractable problems and reduce animal suffering. He's a co-founder, former program director and venture partner at biotech accelerator program IndieBio. Ryan has invested in more than 70 early-stage biotech startups, and served as the head of life sciences at the XPRIZE Foundation. His latest venture, of which he's co-founder and CEO, is Wild Earth, a pet food company that uses cultured protein to create vegan dog food. The company, which was started in 2014, is also working to bring a cruelty-free clean meat cat food to market. In this interview Ryan discusses: • What biohacking is and how it's helping people, animals and planet • The language and messaging vegan brands need to use to get consumers on board with new technology in food • The (perhaps surprising) key mistake food startups make and what to do instead • Why an idea is not enough and what else you need to get investors and partners on board with your business • Why he thinks business plans are dead and what you need instead • How to choose the right accelerator program for your startup • The three questions he asks entrepreneurs before deciding whether to invest in them • Why he chose to go the venture capital investment route for Wild Earth • And much more Visit the Wild Earth website Check out my article on Ryan and Wild Earth on Forbes Find out more about IndieBio life sciences startup accelerator program Brands mentioned in vegan business news roundup: Beyond Meat East Lancashire Health Trust Alexi Lubomirski RESOURCES: My Online PR Course for Vegan Business Owners & Entrepreneurs: Vegans in the Limelight My book Vegan Ventures: Start and Grow an Ethical Business Follow Vegan Business Media on: Facebook   Twitter  Instagram  Connect with me personally at: Facebook  Twitter  LinkedIn

My guest is Alan Clayton of SOSV, who's the Roaming Mentor at the VC and who's been with the company since the beginnings. You might know as SOSV as it's the world's top hardware VC. They're special also in another aspect as unlike other VCs, SOSV runs accelerator programs, such as HAX, HAX Growth, RebelBio, IndieBio, Food-X, Chinaaccelerator, MOX. They are understandably very tech-focused and Alan Clayton is the person who understands people. This means he makes sure you have the right team to deliver the right results as otherwise things can and if they can, then they will go wrong. The question we addressed in this episode is: how can you maximize your success with your team? You can learn in this episode about successful team's composition, the Herrmann Brain Dominance Instrument (HBDI) for testing what areas the team covers, and also how this knowledge can help you pitch your idea better. So in essence we'll go deeper than just talking about the left and right brain thinking. Enjoy this episode! Raw transcript is available at: https://www.thehardwareentrepreneur.com Show highlights can be seen below: Do you use your brain's full capacity? - [3:27] What SOSV stands for and Alan's role in the company – [6:38] Who is Ned Herrmann and how his work is helping startups work more effectively? – [7:48] At which phase of the startup process you will most surely need Alan? - [9:17] How does a startup founders' assessment unfold? - [12:42] Which type of intelligence are you - Captain Kirk, Doctor Spock, Scotty the engineer or Doctor Bones? - [15:04] How to avoid conflicts and benefit from the team diversity at the early stages of a startup? - [21:38] What are the major success factors for hardware startups? - [24:58] What set of skills does a hardware startup CEO need to develop? - [27:20] A Star Trek crash course on pitching - [30:30] If you could time travel and go back in time, what notes would you give yourself? – [34:54] Which book had the biggest impact on his career? – [35:39] Some cultural differences that Alan observed throughout his career – [36:46] Alan's recipe for a good start of the day - [38:55] What is the best way to reach Alan? – [42:20]

I'm so proud to have Dominique Barnes and Michelle Wolf on the show. They are the founders of New Wave Foods. They create seafood in a lab not the ocean. Their first product is recreating shrimp using plant proteins and marine algae. This interview blew my mind. Fresh out of IndieBio, a biotech accelerator, and a $250,000 grant, they are currently raising capital with investors. Their first customer: Google. The lead vegan chef at Googleplex put in an order for 200 pounds. The environmental and social issues of commercial seafood production are numerous and serious. It is precisely what makes New Wave so important. Listen to their story and be inspired: The why behind New Wave Foods Getting the shrimp texture and nutritional profile right Demo day @ IndieBio Fundraising, marketing, and their blueprint to grow the company Stopping slave labor + shrimp fishing The muscular structure of a shrimp Why marine algae is amazing Behind the scenes of the day-to-day @ New Wave Foods On being founders AND roommates Selected links from the episode:New Wave FoodsIndieBioWhy Everyone (Else) Is a Hypocrite: Evolution and the Modular MindSarcomereGoogle